Celecoxib is a generic prescription drug that’s used to treat some kinds of pain and arthritis. Celecoxib comes as an oral capsule. Celecoxib is a generic drug, which means it’s an exact copy of the ...
Zydus Lifesciences Limited, a pharma firm has received final approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, the ...
Strides Pharma has said that its step-down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg, and 400 mg, from the United ...
Celebrex contains the active ingredient celecoxib. It belongs to a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). This drug comes as a capsule that you swallow. The dose of ...
Unichem Laboratories gets USFDA nod to market generic Celecoxib capsules The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, ...
Its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLC's (a subsidiary of Pfizer) Celebrex capsules of strength of 50 mg, 100 mg, 200 mg and 400 mg, the ...
Zydus Lifesciences shares will be in focus after the company received final approval from the United States Food and Drug Administration (USFDA) for its Celecoxib capsules, a medication used for pain ...
PITTSBURGH, Dec. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic ...
Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D. Searle LLC's (a subsidiary of Pfizer Inc ...
Shares of Unichem Laboratories were trading at ₹280.55 per scrip on BSE, up 1.04% from its previous close. Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results